Ihr Browser kann das Objekt leider nicht anzeigen!
Lead WP7a:
Kirsteen Donaldson, FPM, UK
.
Co-Lead:
Ruth Hargreaves,
Pfizer Ltd., UK
Ingrid Klingmann, EFGCP

WP 7 a.: Leading the Examination Process


Objectives


  • To conceive, pilot and implement a standard examination concept with intra-examination and inter-examination controls (years and sites) (TF 1)
  • To enhance the knowledge base of professionals involved in the integrated development of drugs through establishing an exemplary and consistent examination standard across the EU in the discipline
  • To define standards in dealing with ethical issue for the entire PharmaTrain programme (TF 7.2 and para 5).